methyl (2R)-2-({(1M)-5-methyl-1-[3-(trifluoromethyl)phenyl]-1H-pyrazole-3-carbonyl}amino)-2-(thiophen-2-yl)propanoate
methyl (2R)-2-({(1M)-5-methyl-1-[3-(trifluoromethyl)phenyl]-1H-pyrazole-3-carbonyl}amino)-2-(thiophen-2-yl)propanoate
SMILES |
CC1=CC(=NN1C2=CC=CC(=C2)C(F)(F)F)C(=O)N[C@@](C)(C3=CC=CS3)C(=O)OC |
InChIKey |
XCJKFSDARVULKK-IBGZPJMESA-N |
Chemical Properties
Hydrogen bond acceptors |
None |
Hydrogen bond donors |
None |
Rotatable bonds |
None |
Molecular weight (Da) |
|
Bioactivities
|
Receptor |
Activity |
Source |
Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
Receptor |
Activity |
Source |
Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
methyl (2R)-2-({(1M)-5-methyl-1-[3-(trifluoromethyl)phenyl]-1H-pyrazole-3-carbonyl}amino)-2-(thiophen-2-yl)propanoate
Drug properties
Molecular type |
Small molecule |
Physiological/Surrogate |
Surrogate |
Approved drug |
No |
Clinical Trials
Phase I
0
Phase II
0
Phase III
0
Approved
No
Sankey plot
Compound is not listed as a drug.